ObjectiveStillbirth measures provide means to assess adequacy of maternal and perinatal care in a given population. The aim of this study was to describe the determinants of stillbirth in Douala general hospital, Cameroon.ResultsDeterminants of stillbirth in this hospital are: maternal age ≥35 years (OR 1.79, 95% CI 1.26–2.54, p = 0.001), pre-eclampsia/eclampsia (OR 2.97, 95% CI 0.87–8.89, p value of 0.03), diabetes in pregnancy (OR 9.97, 95% CI 1.15–86.86, p = 0.03), stillbirth in previous pregnancies (OR 3.94, CI 2.02–7.7, p < 0.0001), inter-pregnancy interval >2 years (OR 2, 06 CI 1.22–3.49; p = 0,006), referral from another hospital (OR 14.16, 95% CI 7.08–28.3, p < 0.0001), gestational age <37 (OR 19.9, 95% CI 12.3–32.2, p < 0.0001) and >42 (OR 6.27, 95% CI = 0.86–45.2, p = 0.096), congenital malformation (OR 11.09, 95% CI 3.2–38,5, p < 0.0001) and birth weight <2500 g (p < 0.0001).Electronic supplementary materialThe online version of this article (doi:10.1186/s13104-017-2787-2) contains supplementary material, which is available to authorized users.

ObjectiveAdolescent deliveries remain a public health problem in most developing countries. The aim of our study was to determine the prevalence, trends and outcome of adolescent deliveries in an urban setting in Cameroon. We carried out a retrospective register analysis over a 6-year period (January 2010–December 2015) at the Saint Albert Le Grand hospital Douala.ResultsThe overall prevalence of adolescent deliveries was 8.2% (662 out of 8056). There was a significant decrease over the 6-year period (p-trend: < 0.05). Adolescents were at higher risk of preterm deliveries (gestational age < 37 weeks; odds ratio [OR], 1.7; 95% confidence interval [CI]; 1.3–2.2; p < 0.01): low birth weight (defined as birth weight < 2650 g, OR; 1.7, CI 1.4–2.2, p < 0.01) and asphyxia at 1st minute (OR, 1.5; 95% CI 1.1–2.2; p = 0.02). There was no difference in delivery outcomes between early and late adolescents. Our results suggest that the prevalence of adolescent deliveries is lower in urban settings. Adolescent deliveries are more likely to result in adverse fetal outcomes than adult deliveries. Measures directed towards the prevention of adolescent pregnancies should be implemented to reduce neonatal morbidity and mortality.Electronic supplementary materialThe online version of this article (10.1186/s13104-018-3578-0) contains supplementary material, which is available to authorized users.

Background: Contraception has been practice in the last few decades in order to prevent unwanted pregnancies and to safe women from criminal abortions and its complications. Case presentation: We report 2 cases of ectopic pregnancies diagnosed at 8 and 7 weeks of amenorrhea after the removal of levonorgestrel -containing implants in two females 28 and 32 years old respectively. The ectopic pregnancies occurred between 4-6 weeks following the removal of the implants. The patients were both manged with laparoscopy in Douala general hospital. Conclusion: Due to the limited data on the relationship between progestin implants and ectopic pregnancy, the authors advise that, after removal of the implants patients should not have unprotected sexual intercourse for about three months so as to allow ciliary functions to return to normal.

IntroductionOne of the most recognized factors of maternal and neonatal outcome pertaining to the peripartum period is the duration of labour. Finding a drug that will decrease the duration of labour with no effects on mother and foetus will be welcomed. Thereby in this study we aimed to evaluate the effects of phloroglucinol on the duration of the active phase of labour.MethodsWe did a single blinded placebo controlled randomised 1:1 parallel designed superiority trial between January and June 2017 in Douala general hospital. Participants greater than 18 years with singleton uncomplicated pregnancy who consented following randomisation, were administered either 80mg/8ml intravenous phloroglucinol or 8ml of sterile water when in active labour. The primary outcome was the duration of labour. Modified intention to treat analysis was done with the level of significance set at a p value of 0.05.Results122 participants received the intervention. The mean total duration labour in the treatment and placebo group were 216.8 ± 38.7 and 358.5 ± 65.8 respectively (p value = 0.243). The mean duration of the active phase of labour in the treatment and placebo group were 183.0±35.6 and 316.0±52.2 respectively (p value = 0.046). The mean rate of cervical dilatation in the treatment and placebo group were 2.1 ± 0.4 and 1.3 ± 0.4 respectively (p value = 0.322). There was no difference in maternal and foetal outcomes between the two groups.ConclusionPhloroglucinol shortens the duration of active phase of labour by about 2 hours (42%). It is safe to mother and baby and does not cause adverse foetal or maternal outcomes.